Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study
Abstract Objective The use of intrapleural tissue plasminogen activator (tPA) and dornase alfa (DNase) is common in the management of pleural space infection. We review our experience with the efficacy and safety of this therapy. We performed a single center, retrospective study of consecutive patie...
Main Authors: | Chuan Jiang, Meng Xie, Kelly Cervellione, Craig Thurm |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13104-020-05210-2 |
Similar Items
-
Tissue plasminogen activator with prolonged dwell time effectively evacuates pleural effusions
by: Alexandra Townsend, et al.
Published: (2022-12-01) -
Management of Pleural Infection: A Historical Review and Updates
by: Thomas Presti, et al.
Published: (2024-04-01) -
A feasibility randomised trial comparing therapeutic thoracentesis to chest tube insertion for the management of pleural infection: results from the ACTion trial
by: David T. Arnold, et al.
Published: (2022-08-01) -
Pleural Space Infections
by: Sean P. F. Foley, et al.
Published: (2023-01-01) -
Intrapleural Tenecteplase Therapy in Treatment of Loculated Parapneumonic Pleural Effusions and Empyema
by: Alaa Refaat, et al.
Published: (2014-10-01)